Chronic Kidney Disease and Hypertension
Management of Hypertension: Current Practice and the Application of Landmark Trials, Page: 135-143
2018
- 2Citations
- 4Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Hypertension can cause kidney disease and kidney disease can cause hypertension. However, hypertension may cause progressive kidney disease only in genetically susceptible individuals. The second most common cause of end-stage renal disease continues to be hypertension. Increased blood pressure participates in the pathogenesis of renal disease and the kidney is crucial in the long-term regulation of blood pressure. The development of hypertension and kidney damage is well-documented in many well-characterized animal models of hypertension. Attenuating the development and severity of hypertension prevents the development of end-organ damage. Hypertensive nephrosclerosis is a non-specific clinical diagnosis given to patients with chronic kidney disease, low-level proteinuria, and elevated blood pressure. Arterionephrosclerosis has been suggested as the clinical diagnosis of patients with chronic kidney disease and elevated blood pressure in the absence of diabetes or known genetic cause. In patients with a known genetic cause, the term glomerulosclerosis, preceded by the genetic cause, should used, for instance, APOL1-associated glomerulosclerosis, GSTM1-associated glomerulosclerosis. Increased sodium intake, inflammation, and oxidative stress are interrelated and important in the pathogenesis of hypertension and kidney disease. It is likely that hypertension and kidney disease may share the same causes.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85083430882&origin=inward; http://dx.doi.org/10.1007/978-3-319-92946-0_8; http://link.springer.com/10.1007/978-3-319-92946-0_8; https://dx.doi.org/10.1007/978-3-319-92946-0_8; https://link.springer.com/chapter/10.1007/978-3-319-92946-0_8
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know